- Home
- SBFM vs RVPH Comparison
SBFM vs RVPH Comparison
Compare SBFM & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- RVPH
- Stock Information
- Founded
- SBFM 2006
- RVPH 2006
- Country
- SBFM United States
- RVPH United States
- Employees
- SBFM N/A
- RVPH N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- SBFM Health Care
- RVPH Health Care
- Exchange
- SBFM Nasdaq
- RVPH Nasdaq
- Market Cap
- SBFM 4.9M
- RVPH N/A
- IPO Year
- SBFM N/A
- RVPH N/A
- Fundamental
- Price
- SBFM $1.25
- RVPH $0.78
- Analyst Decision
- SBFM Strong Buy
- RVPH Strong Buy
- Analyst Count
- SBFM 1
- RVPH 5
- Target Price
- SBFM $15.00
- RVPH $10.00
- AVG Volume (30 Days)
- SBFM 3.7M
- RVPH 967.2K
- Earning Date
- SBFM 05-19-2025
- RVPH 05-13-2025
- Dividend Yield
- SBFM N/A
- RVPH N/A
- EPS Growth
- SBFM N/A
- RVPH N/A
- EPS
- SBFM N/A
- RVPH N/A
- Revenue
- SBFM $34,874,283.00
- RVPH N/A
- Revenue This Year
- SBFM $192.48
- RVPH N/A
- Revenue Next Year
- SBFM N/A
- RVPH N/A
- P/E Ratio
- SBFM N/A
- RVPH N/A
- Revenue Growth
- SBFM 44.75
- RVPH N/A
- 52 Week Low
- SBFM $1.19
- RVPH $0.49
- 52 Week High
- SBFM $91.40
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- SBFM 27.96
- RVPH 44.25
- Support Level
- SBFM $1.36
- RVPH $0.68
- Resistance Level
- SBFM $1.65
- RVPH $0.81
- Average True Range (ATR)
- SBFM 0.31
- RVPH 0.12
- MACD
- SBFM -0.04
- RVPH 0.04
- Stochastic Oscillator
- SBFM 2.97
- RVPH 54.72
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.